Teva Pharmaceuticals will pay New York $523 million during an 18-year span for its role in helping fuel the Empire State’s opioid crisis, Attorney General Letitia James said Thursday.

James said the deal with Teva Pharmaceuticals, Ltd., subsidiary Teva Pharmaceuticals US and affiliate arms of the Tel Aviv, Israel-based company is the largest such agreement during her four years in office. 

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]